Similar articles

• Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

  Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T. Van Ganse E, et al. Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003. Clin Ther. 2007. PMID: 17919548
• Prevalence of dyslipidemia and its associated factors among Jordanian adults.

  Khader YS, Batieha A, El-Khateeb M, Al Omari M, Ajlouni K. Khader YS, et al. J Clin Lipidol. 2010 Jan-Feb;4(1):53-8. doi: 10.1016/j.jacl.2009.12.004. Epub 2009 Dec 22. J Clin Lipidol. 2010. PMID: 21122627
• Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.

  Odenigbo CU, Oguejiofor OC, Odenigbo UM, Ibeh CC, Ajaero CN, Odike MA. Odenigbo CU, et al. Niger J Clin Pract. 2008 Dec;11(4):330-5. Niger J Clin Pract. 2008. PMID: 19320405
• Dyslipidemia therapy update: the importance of full lipid profile assessment.

  Menown IB, Murtagh G, Maher V, Cooney MT, Graham IM, Tomkin G. Menown IB, et al. Adv Ther. 2009 Jul;26(7):711-8. doi: 10.1007/s12325-009-0052-3. Epub 2009 Jul 27. Adv Ther. 2009. PMID: 19649582 Review.
• Cardiovascular disease prevention tailored for women.

  Engberding N, Wenger NK. Engberding N, et al. Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1123-34. doi: 10.1586/14779072.6.8.1123. Expert Rev Cardiovasc Ther. 2008. PMID: 18793115 Review.